Sensitive and specific detection of the non-human sialic Acid N-glycolylneuraminic acid in human tissues and biotherapeutic products - Wikidata - wikimedia - TriplyDB

Sensitive and specific detection of the non-human sialic Acid N-glycolylneuraminic acid in human tissues and biotherapeutic products

Sensitive and specific detection of the non-human sialic Acid N-glycolylneuraminic acid in human tissues and biotherapeutic products

http://www.wikidata.org/entity/Q33401246

about

Generation and characterization of transgene-free human induced pluripotent stem cells and conversion to putative clinical-grade status Metabolism of vertebrate amino sugars with N-glycolyl groups: elucidating the intracellular fate of the non-human sialic acid N-glycolylneuraminic acid Distribution of the Galβ1-4Gal epitope among birds: species-specific loss of the glycan structure in chicken and its relatives Sexual selection by female immunity against paternal antigens can fix loss of function alleles Parallel evolution of a self-signal: humans and new world monkeys independently lost the cell surface sugar Neu5Gc Lipid-Based Drug Delivery Systems in Cancer Therapy: What Is Available and What Is Yet to Come.Novel mechanism for the generation of human xeno-autoantibodies against the nonhuman sialic acid N-glycolylneuraminic acid.Implications of the presence of N-glycolylneuraminic acid in recombinant therapeutic glycoproteins.A human-specific deletion in mouse Cmah increases disease severity in the mdx model of Duchenne muscular dystrophy Human xeno-autoantibodies against a non-human sialic acid serve as novel serum biomarkers and immunotherapeutics in cancer.A sialylated glycan microarray reveals novel interactions of modified sialic acids with proteins and viruses.Early murine T-lymphocyte activation is accompanied by a switch from N-Glycolyl- to N-acetyl-neuraminic acid and generation of ligands for siglec-E Ganglioside biochemistry Preferential Accumulation of 14C-N-Glycolylneuraminic Acid over 14C-N-Acetylneuraminic Acid in the Rat Brain after Tail Vein Injection Utilizing CMP-Sialic Acid Analogs to Unravel Neisseria gonorrhoeae Lipooligosaccharide-Mediated Complement Resistance and Design Novel Therapeutics.Cross-comparison of protein recognition of sialic acid diversity on two novel sialoglycan microarrays.Metabolism of vertebrate amino sugars with N-glycolyl groups: mechanisms underlying gastrointestinal incorporation of the non-human sialic acid xeno-autoantigen N-glycolylneuraminic acid.Metabolism of vertebrate amino sugars with N-glycolyl groups: incorporation of N-glycolylhexosamines into mammalian glycans by feeding N-glycolylgalactosamine Rabbit antithymocyte globulin-induced serum sickness disease and human kidney graft survival.N-Glycolylneuraminic acid deficiency worsens cardiac and skeletal muscle pathophysiology in α-sarcoglycan-deficient mice Evidence for a novel human-specific xeno-auto-antibody response against vascular endothelium.Involvement of a non-human sialic Acid in human cancer.Altered sphingolipid metabolism induced by tumor hypoxia - new vistas in glycolipid tumor markers.Physiological Exploration of the Long Term Evolutionary Selection against Expression of N-Glycolylneuraminic Acid in the Brain.Worldwide survey of published procedures to culture human embryonic stem cells.Use of IgY antibodies and semiconductor nanocrystal detection in cancer biomarker quantitation.Characterization of O-acetylation in sialoglycans by MALDI-MS using a combination of methylamidation and permethylation.Production platforms for biotherapeutic glycoproteins. Occurrence, impact, and challenges of non-human sialylation.Recent advances in technology supporting biopharmaceutical production from mammalian cells.Innovative approach for improved rFVIII concentrate.No evidence for αGal epitope transfer from media containing FCS onto human endothelial cells in culture.The nutritional role of free sialic acid, a human milk monosaccharide, and its application as a functional food ingredient.Novel, human cell line-derived recombinant factor VIII (human-cl rhFVIII; Nuwiq(®) ) in adults with severe haemophilia A: efficacy and safety.Biochemical, Cellular, Physiological, and Pathological Consequences of Human Loss of N-Glycolylneuraminic Acid.First quantification of alpha-Gal epitope in current glutaraldehyde-fixed heart valve bioprostheses.Characterization of immunogenic Neu5Gc in bioprosthetic heart valves.Potential impact of the non-human sialic acid N-glycolylneuraminic acid on transplant rejection risk.Developmental changes in the level of free and conjugated sialic acids, Neu5Ac, Neu5Gc and KDN in different organs of pig: a LC-MS/MS quantitative analyses.Phylogenetic distribution of CMP-Neu5Ac hydroxylase (CMAH), the enzyme synthetizing the pro-inflammatory human xeno-antigen Neu5Gc.LC-MS/MS glycomic analyses of free and conjugated forms of the sialic acids, Neu5Ac, Neu5Gc and KDN in human throat cancers.

P2860

Q21999273-211F59CF-18A1-4B75-A61B-393DB4D7659D Q24338142-8C1362F2-B714-4A7C-9D66-72FEC2A0E8D1 Q28488232-319BBC04-DCA4-4E1A-B2A0-EB5604F3D3E0 Q28511125-F2156DE3-927D-471F-BA85-019AD1F8B45E Q28654676-E422652A-889F-4B3D-946A-275C5AB950CD Q30366990-FB9CB4E0-2D71-4376-881A-DE48BA596DB8 Q34044438-D19FABBC-6242-4F99-986B-84D62EF9BAE1 Q34127850-C3C6BDF4-4B56-4585-BC2B-A2CF601E16B9 Q34175938-7AFA03F1-A14F-4B3E-ACB4-61A675A7189D Q34900010-2E821379-E1E6-47A9-A0B1-6065EA950C98 Q35213210-3687934C-356C-448F-8790-A836717E5479 Q35266949-3E2645D6-6E3C-46F0-BD89-F4391E7D5F4E Q35361488-1A90DBA7-A02B-4835-ADE8-0C8BA0B5DFC4 Q35670865-17356396-3CA9-4649-B9AD-4C9F21321C15 Q35859218-99015271-3E66-4BBC-BB3E-914CCB2BE0D7 Q36080527-37B758D7-E549-475E-BDB1-DF281321B6AB Q36217161-8AB7E2DF-A797-474E-9B45-EBB0B3179BA4 Q36217214-E1DE7B6D-FEF9-4E5C-9B6B-D54B9034C76B Q36335918-3C0FD839-745D-40B3-9674-60C39AEB6167 Q36900455-89933A63-903B-4B46-B9D8-65FD02A1A88D Q37472019-9AE2C25C-4D1E-40FE-8AB9-4A205C0691B3 Q37592596-6C056D29-CDE1-4ECC-8E41-D0C066F28CD3 Q37632848-C4EAEBF8-3183-40BE-8C69-FE93A04DB5A3 Q37648392-9FC94F8C-5B1A-4042-91CF-BB11222EF283 Q37669453-3D9A80FF-0AA1-4955-8610-002600B97B61 Q37734424-174489B2-E833-45DB-9C6A-2501A0D2D017 Q37741292-DEFEBDF2-4036-4D15-B0F3-C69D586C670A Q38012151-791F39C4-200C-46EA-8928-B61D78902EB3 Q38050998-543FD1C5-517A-4D23-AE34-4BB62DC59A40 Q38207134-F69E5B35-0F58-4961-BDC7-3BADFD3CDD8C Q38296915-E94C188A-4214-4C94-BB48-FE272E7C69CC Q38538651-7C516DE5-1061-4CA6-8CEC-B292E9387C34 Q38840145-7866C021-B174-4AD0-B170-6EE2B1BBAA38 Q39250748-01D9BFEF-18CF-4A1B-8C31-BDFE00FED2CF Q39382269-96217AF3-7960-4109-989D-486FE1BEF4AF Q40545748-DC78A691-38D4-470E-AC70-A916927BFA25 Q41816408-AC59761F-68E6-48E9-B7F8-3442FAAE962E Q44008036-4BE02110-979E-480B-A9FB-C03AA94FFBAE Q46247720-6B305515-A633-4318-A53C-6FCC9F150B6E Q46280192-22C1E817-349C-4983-95F6-77221B75745B

P2860

Sensitive and specific detection of the non-human sialic Acid N-glycolylneuraminic acid in human tissues and biotherapeutic products

http://www.wikidata.org/entity/Q33401246

description

2009 nî lūn-bûn

@nan

2009 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Sensitive and specific detecti ...... es and biotherapeutic products

@ast

Sensitive and specific detecti ...... es and biotherapeutic products

@en

type

label

Sensitive and specific detecti ...... es and biotherapeutic products

@ast

Sensitive and specific detecti ...... es and biotherapeutic products

@en

prefLabel

Sensitive and specific detecti ...... es and biotherapeutic products

@ast

Sensitive and specific detecti ...... es and biotherapeutic products

@en

P1433

Q33401246-3824A9C2-B48A-4671-AD09-850085C74CA4

P1476

Q33401246-4F23DF7C-5523-4C90-A999-AA77D39900E9

P2093

Q33401246-04B1FE85-CAB1-4C66-AF39-8037E5B31C43

Q33401246-413D7556-42FC-4B18-BE1C-29C41EE98B23

Q33401246-439228DD-8C74-4282-839A-DC67660AA3DC

Q33401246-5FAB7DB3-E3BF-4969-87AD-027A8EB0EDDB

Q33401246-7DDF9020-0F7F-47C9-B3FE-42A68BD9D8C3

Q33401246-87C4A702-7061-4218-B495-264025975213

Q33401246-D7B22291-7AC0-4AA7-B8DE-A78BFB1655CB

Q33401246-DFEA582D-2421-40A6-9427-F9FB2BB55D7D

Q33401246-FA043B4E-424D-4628-B6E9-059C440DB1BE

P2860

Q33401246-01DE906A-931B-42CE-B224-5916F6F8EA3D

Q33401246-0A39D85D-7668-4DCD-9787-8A7F44F028FD

Q33401246-0EF68FD3-F49D-4B3D-AA53-67FE6021AF64

Q33401246-1761CC0B-0415-457C-BE36-C60F0EEF7C0E

Q33401246-22ACFE7B-ADE4-4A3D-BB7C-86F342D2DB04

Q33401246-2A13CDCD-FA76-4BC5-8B08-E9635C0B4192

Q33401246-2BFDB772-BA78-48E8-AA0B-B39098846857

Q33401246-37DD0378-4AD7-4A23-A06B-4F96E752FC5E

Q33401246-42764EE5-B1E2-44C8-96B7-97E4FF800199

Q33401246-47628831-C6E9-401F-84EC-F66BAD4D213B

P304

Q33401246-19DBC29C-5BF5-4C91-B098-5C337EEF43CA

P31

Q33401246-DB2936CC-8E04-450D-B431-18CC967A3A3D

P356

Q33401246-6D5868CD-5DE0-4B33-8B5D-667B35EDFC32

P407

Q33401246-CF270DC7-9440-43AC-9A16-89D77CC84871

P433

Q33401246-3F7DCF97-E5A6-432C-9464-1A2D9D9ECC73

P478

Q33401246-C0AC5C10-35CC-4A2B-93D7-920B743C0126

P577

Q33401246-D173AB98-9B00-49B6-A6DB-718E7C6579D8

P5875

Q33401246-C43097CA-DCFE-4EEE-964E-67EA93156F21

P698

Q33401246-FD40CB55-A32F-49E2-8A13-956AB2AC3793

P932

Q33401246-D3C64807-D49D-4F0F-9BFF-47EEDCA07B55

P356

JOURNAL.PONE.0004241

P1433

P1476

Sensitive and specific detecti ...... es and biotherapeutic products

@en

P2093

Ajit Varki

http://www.w3.org/2001/XMLSchema#string

Darius Ghaderi

http://www.w3.org/2001/XMLSchema#string

Els C M Brinkman-Van der Linden

http://www.w3.org/2001/XMLSchema#string

Hai Yu

http://www.w3.org/2001/XMLSchema#string

Nancy Hurtado-Ziola

http://www.w3.org/2001/XMLSchema#string

Nissi M Varki

http://www.w3.org/2001/XMLSchema#string

Sandra L Diaz

http://www.w3.org/2001/XMLSchema#string

Vered Padler-Karavani

http://www.w3.org/2001/XMLSchema#string

Xi Chen

http://www.w3.org/2001/XMLSchema#string

P2860

Human uptake and incorporation of an immunogenic nonhuman dietary sialic acid

Incorporation of a non-human glycan mediates human susceptibility to a bacterial toxin

Cetuximab-induced anaphylaxis and IgE specific for galactose-alpha-1,3-galactose.

N-glycolylneuraminic acid deficiency in mice: implications for human biology and evolution

Species-specific variation in glycosylation of IgG: evidence for the species-specific sialylation and branch-specific galactosylation and importance for engineering recombinant glycoprotein therapeutics.

N-glycolylneuraminic acid xenoantigen contamination of human embryonic and mesenchymal stem cells is substantially reversible.

Efficient chemoenzymatic synthesis of biotinylated human serum albumin-sialoglycoside conjugates containing O-acetylated sialic acids.

Structural analysis of alpha-Gal and new non-Gal carbohydrate epitopes from specific pathogen-free miniature pig kidney.

Approaches to the release of a master cell bank of PER.C6 cells; a novel cell substrate for the manufacture of human vaccines.

Model-building study of the combining sites of two antibodies to alpha (1----6)dextran.

P304

e4241

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0004241

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P577

2009-01-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23804040

http://www.w3.org/2001/XMLSchema#string

P698

19156207

http://www.w3.org/2001/XMLSchema#string

P932

2626223

http://www.w3.org/2001/XMLSchema#string